209 related articles for article (PubMed ID: 26852126)
1. Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.
Gamboa GV; Palma SD; Lifschitz A; Ballent M; Lanusse C; Passirani C; Benoit JP; Allemandi DA
Parasitol Res; 2016 May; 115(5):1945-53. PubMed ID: 26852126
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating the antiparasitic activity of the multifaceted drug ivermectin through a polymer nanocapsule formulation.
de Souza ZC; Júnior FHX; Pinheiro IO; de Souza Rebouças J; de Abreu BO; Mesquita PRR; de Medeiros Rodrigues F; Quadros HC; Mendes TMF; Nguewa P; Allegretti SM; Farias LP; Formiga FR
Int J Pharm; 2023 May; 639():122965. PubMed ID: 37084836
[TBL] [Abstract][Full Text] [Related]
3. Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.
Lu M; Xiong D; Sun W; Yu T; Hu Z; Ding J; Cai Y; Yang S; Pan B
Drug Deliv; 2017 Nov; 24(1):622-631. PubMed ID: 28282989
[TBL] [Abstract][Full Text] [Related]
4. Integrated assessment of ivermectin pharmacokinetics, efficacy against resistant Haemonchus contortus and P-glycoprotein expression in lambs treated at three different dosage levels.
Alvarez L; Suarez G; Ceballos L; Moreno L; Canton C; Lifschitz A; Maté L; Ballent M; Virkel G; Lanusse C
Vet Parasitol; 2015 May; 210(1-2):53-63. PubMed ID: 25841863
[TBL] [Abstract][Full Text] [Related]
5. Field trial assessment of ivermectin pharmacokinetics and efficacy against susceptible and resistant nematode populations in cattle.
Canton C; Canton L; Domínguez MP; Moreno L; Lanusse C; Alvarez L; Ceballos L
Vet Parasitol; 2018 May; 256():43-49. PubMed ID: 29887029
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneously injected ivermectin-loaded mixed micelles: formulation, pharmacokinetics and local irritation study.
Dong J; Song X; Lian X; Fu Y; Gong T
Drug Deliv; 2016 Sep; 23(7):2220-2227. PubMed ID: 25188004
[TBL] [Abstract][Full Text] [Related]
7. Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration.
Bassissi F; Lespine A; Alvinerie M
Parasitol Res; 2006 Feb; 98(3):244-9. PubMed ID: 16341879
[TBL] [Abstract][Full Text] [Related]
8. Ivermectin lipid-based nanocarriers as novel formulations against head lice.
Ullio-Gamboa G; Palma S; Benoit JP; Allemandi D; Picollo MI; Toloza AC
Parasitol Res; 2017 Aug; 116(8):2111-2117. PubMed ID: 28523490
[TBL] [Abstract][Full Text] [Related]
9. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds.
Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C
Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381
[TBL] [Abstract][Full Text] [Related]
10. The effect of sesame and sunflower oils on the plasma disposition of ivermectin in goats.
Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
J Vet Pharmacol Ther; 2008 Oct; 31(5):472-8. PubMed ID: 19000267
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep.
Canga AG; Sahagun A; Diez MJ; Fernandez N; Sierra M; Garcia JJ
Am J Vet Res; 2007 Jan; 68(1):101-6. PubMed ID: 17199426
[TBL] [Abstract][Full Text] [Related]
12. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules.
Lollo G; Ullio-Gamboa G; Fuentes E; Matha K; Lautram N; Benoit JP
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():859-867. PubMed ID: 30033321
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
[TBL] [Abstract][Full Text] [Related]
14. Tumour targeting of lipid nanocapsules grafted with cRGD peptides.
Hirsjärvi S; Belloche C; Hindré F; Garcion E; Benoit JP
Eur J Pharm Biopharm; 2014 May; 87(1):152-9. PubMed ID: 24361535
[TBL] [Abstract][Full Text] [Related]
15. Experimental study of pharmacokinetics of external, whole-body bathing application of ivermectin.
Miyajima A; Komoda M; Akagi K; Yuzawa K; Yoshimasu T; Yamamoto Y; Hirota T
J Dermatol; 2015 Jan; 42(1):87-9. PubMed ID: 25492083
[TBL] [Abstract][Full Text] [Related]
16. Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits.
Gokbulut C; Biligili A; Kart A; Turgut C
Lab Anim; 2010 Apr; 44(2):138-42. PubMed ID: 19959569
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.
Ding B; Chen P; Kong Y; Zhai Y; Pang X; Dou J; Zhai G
J Drug Target; 2014 Jan; 22(1):67-75. PubMed ID: 24099639
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis.
Ahmadpour E; Godrati-Azar Z; Spotin A; Norouzi R; Hamishehkar H; Nami S; Heydarian P; Rajabi S; Mohammadi M; Perez-Cordon G
Parasit Vectors; 2019 Oct; 12(1):469. PubMed ID: 31601244
[TBL] [Abstract][Full Text] [Related]
19. Tablets based on compressed zein microspheres for sustained oral administration: design, pharmacokinetics, and clinical study.
Gong SJ; Sun SX; Sun QS; Wang JY; Liu XM; Liu GY
J Biomater Appl; 2011 Aug; 26(2):195-208. PubMed ID: 20418265
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
